Provided by Tiger Trade Technology Pte. Ltd.

RxSIGHT, INC.

4.90
+0.13002.73%
Post-market: 4.86-0.0400-0.82%19:30 EDT
Volume:705.66K
Turnover:3.44M
Market Cap:202.84M
PE:-4.30
High:4.99
Open:4.80
Low:4.67
Close:4.77
52wk High:13.22
52wk Low:4.48
Shares:41.40M
Float Shares:33.77M
Volume Ratio:0.74
T/O Rate:2.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1385
EPS(LYR):-0.9533
ROE:-17.35%
ROA:-10.41%
PB:0.77
PE(LYR):-5.14

Loading ...

Rxsight Says Q2 Results Hit by More Widespread Competitive Trialing

Reuters
·
Jul 07

Alcon, RxSight announce collaboration to develop adjustable PCIOLs

TIPRANKS
·
Jul 07

Alcon, Rxsight Partner to Develop Adjustable Presbyopia-correcting Intraocular Lenses

Reuters
·
Jul 07

Alcon Notifies Availability of Press Release on Rxsight Collaboration for Adjustable Pciols

Reuters
·
Jul 07

Alcon, Rxsight Collaborate to Develop Adjustable Presbyopia-correcting Intraocular Lenses

Reuters
·
Jul 07

Rxsight Forecasts 2026 Revenue of $140 Million-$160 Million, Cuts Sales Outlook to $110 Million-$120 Million

Reuters
·
Jul 07

Rxsight - Guides 2026 Revenue of $140-$160 Mln

THOMSON REUTERS
·
Jul 07

Rxsight Q2 Revenue USD 27 Million VS. Ibes Estimate USD 32.1 Million

THOMSON REUTERS
·
Jul 07

Rxsight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

THOMSON REUTERS
·
Jul 07

Alcon AG - Rxsight to Receive $60 Mln Upfront Payment Under Agreement

THOMSON REUTERS
·
Jul 07

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

GlobeNewswire
·
Jul 07

RxSight Stockholders Back Leadership at 2026 Annual Meeting

TIPRANKS
·
Jun 17

RxSight stockholders approve advisory executive pay plan at annual meeting

Reuters
·
Jun 17

RxSight Securities Lawsuit Advances After Court Denies Dismissal Bid

TIPRANKS
·
May 30

Analysts Conflicted on These Healthcare Names: RxSight (RXST), Liquidia Technologies (LQDA) and Krystal Biotech (KRYS)

TIPRANKS
·
May 14

RxSight Earnings Call Balances Growth With Headwinds

TIPRANKS
·
May 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: Voyager Therapeutics (VYGR), Alpha Teknova (TKNO) and RxSight (RXST)

TIPRANKS
·
May 09

RxSight price target lowered to $11 from $13 at Needham

TIPRANKS
·
May 07

Needham Cuts Price Target on RxSight to $11 From $13, Keeps Buy Rating

MT Newswires Live
·
May 07

RxSight Is Maintained at Buy by Needham

Dow Jones
·
May 07